Trials / Unknown
UnknownNCT01473849
Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients
Non-interventional, Prospective Study to Evaluate the Impact of CMV Replication Over Hepatitis C Recurrence in Liver Transplant Recipients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 179 (estimated)
- Sponsor
- Sociedad Española de Trasplante Hepático · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The relationship between cytomegalovirus infection and recurrence of hepatitis C in liver transplant recipients remains controversial. Although some studies (Teixeira et al., 2000; Singh et al., 2005)have not found an association between recurrence of hepatitis C and CMV infection, studies such as Rosen et al. show that 50% of patients with CMV infection suffered cirrhosis durig follow-up period, while between not-infected patients the rate was 11%. To clarify this question, a non-interventional study will be carried out in order to assess if CMV replication is a risk factor for graft dysfunction in liver transplant recipients.
Conditions
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2013-03-01
- Completion
- 2013-04-01
- First posted
- 2011-11-17
- Last updated
- 2012-12-20
Locations
13 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01473849. Inclusion in this directory is not an endorsement.